Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
NCT ID: NCT05810506
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
82 participants
OBSERVATIONAL
2021-10-01
2023-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195
Investigation of the Effects of Different Levels of Obesity on the Respiratory System
NCT04780828
Comparison of Triglyceride-Glucose Index and Atherogenic Indices Between Patients With Lipedema and Obese Controls
NCT07240298
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
NCT06257732
Aronia and Non-alcoholic Fatty Liver Disease
NCT06450769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Anthropometric Measurements The data were collected using a questionnaire form and face-to-face interview method. In the study, individuals' body weight (kg), height (cm), waist circumference (cm), hip circumference (cm), neck circumference (cm) measurements were taken in accordance with the method, and these measurement values were used to measure BMI, waist-height ratio, waist-hip ratio, body composition (fat mass, muscle mass, etc.), body shape index, body roundness index, visceral adiposity index measurements were calculated. Body mass index was calculated by dividing the body weight by the square of the height. Other anthropometric measurements and ratios were calculated using appropriate formulas.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy individuals; they were required to sign the voluntary consent form, not consume alcohol, be between 30-64 years old, and not have any acute or chronic diseases. Individuals outside these criteria were not included in the study. In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
NAFLD
NAFLD patients included in the study should sign a voluntary consent form, do not consume alcohol, be between 30-64 years old, have been diagnosed with NAFLD by applying to the gastroenterology outpatient clinic, have no other diseases, and should not use medication. In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* do not consume alcohol
* be between 30-64 years old
* have been diagnosed with NAFLD by applying to the gastroenterology outpatient clinic
* have no other diseases
* should not use medication
* should sign a voluntary consent form
* do not consume alcohol
* be between 30-64 years old
* not have any acute or chronic diseases
Exclusion Criteria
* not be between 30-64 years old
* being pregnant or lactating
* any surgery in the last 3 months
* Not being diagnosed with NAFLD
* Hepatitis B-C, Wilson's disease, autoimmune liver diseases, cancer, cirrhosis, inflammatory bowel diseases, celiac, diabetes, cystic fibrosis, hereditary diseases, irritable bowel syndrome, kidney diseases, AIDS-HIV etc. have a disease
* using any medication other than fatty liver
* consuming alcohol
* any acute or chronic illness
* being pregnant-lactating
* using any medicine
* not be between 30-64 years old
30 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bandırma Onyedi Eylül University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuba ONAY
Research Assistant Doctor /Principal İnvestigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bandırma onyedi eylül unıversıty
Bandırma, Balıkesir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tuba ONAY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.